The in vitro cytotoxicity of the ligands and related complexes against HCT-116 colorectal carcinoma (both p53-wildtype and p53-knockout cells) and MCF-7 breast cancer cell lines was investigated by MTT assay. This evidence concerns the gene TP53 and breast cancer.